120 results
Page 3 of 6
8-K/A
EX-99.1
xld2a6k9mfum63vgmeja
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
ltk 57aer4qzp1
28 Oct 21
Definitive proxy
3:07pm
D
otnqdw4coqpnaiir
28 Oct 21
$4.31M in equity, sold $4.31M, 54 investors
11:29am
8-K
EX-2.1
dp4obt
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
pa69cgh4 40fpg7
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
seazzf80rao h9vp
24 Sep 21
Annual report
7:31am
10-K
EX-10.10
98t9n 250tkjx0pxok5j
24 Sep 21
Annual report
7:31am
424B3
b7vcf7565wj0 kp
22 Jul 21
Prospectus supplement
10:27am
D
dpf km6z3
19 Jul 21
$12M in equity / options, sold $12M, 1 investor
6:13am
8-K
EX-10.1
gb2jpsh5is8
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-10.2
g8jhqe5
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-99.1
6nb8r4b2taxg1q 5h32c
28 Apr 21
Regulation FD Disclosure
11:43am